- Trump administration will bring special ed to HHSInfant mortality rate dips, OTC naloxone options rise, and other health news from Morning RoundsSTAT · 1mo ago↗ source
- STAT+: Following dispute with FDA, UniQure is cleared to submit Huntington’s treatment for approvalThe FDA has reversed its opposition to a closely watched experimental treatment for Huntington’s disease, clearing a path for its maker.STAT · 1mo ago↗ source
- Jazz turns to AbCellera for T cell engagers in up to $4.1B partnershipFor much of its first decade, Canadian antibody developer AbCellera signed partnership after partnership, securing 40 biopharma alliances that led to more than a dozen clinical-stage drug candidate…Endpoints · 1mo ago